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4.013
nducible clindamycin-resistance in clinical staphylococ-
al isolates with reduced vancomycin susceptibility in a
niversity Teaching Hospital
. Olayinka1,∗, A. Olayinka2, A. Obajuluwa1, J. Onaolapo1,
. Olurinola1
Ahmadu Bello University, Zaria, Nigeria
Ahmadu Bello University Teaching Hospital, Shika-Zaria,
igeria
Background: The chemotherapy of staphylococcal infec-
ions has been complicated by evolution of multidrug
esistant strains, especially the methicillin-resistant Staphy-
ococcus aureus (MRSA) now treated with various groups
f antimicrobial agents, including, the glycopeptides
vancomycin); and the macrolides, lincosamides and strep-
ogramin B (MLSB) class of antibiotics. The risk of clinical
ailure during therapy is increasingly being reported while
herapeutic failures due to MLSB-inducible resistance (MLSB-
) is becoming more frequent. The study determined
revalence of inducible erm-mediated clindamycin resis-
ance (MLSB-i) in clinical staphylococcal isolates with
educed vancomycin susceptibility in a University Teaching
ospital was determined.
Methods: Suspected staphylococcal isolates from spec-
men submitted to the Medical Microbiology laboratory
ere screened for vancomycin resistance on vancomycin-
gar screening plates; Brain Heart agar supplemented with
!g/ml vancomycin (BHI-V6); Mannitol Salt agar supple-
ented with 4 !g/ml vancomycin (MSA-V4) and conﬁrmed
y E-test. All isolates with vancomycin MIC of 1.5 to 2
ere tested for MLSB-i by the double-disc diffusion, D-test
sing erythromycin (ER, 15!g) and clindamycin (CL, 2 !g)
iscs placed 15mm-18mm apart on Muller-Hinton agar plates
noculated with the test organism.
Results: A total of 43/195 (22.1%) grew on BHI-V6 within
4hrs while 66/195 (33.8%) grew on MSA-V4 in 24—48 hrs of
ncubation. However, only 36 isolates had vancomycin MIC
f between 1.5 to 2.0. Only 41.6% (15/36) of the isolates
ave a positive D-test indicative of MLSB-i.
Conclusion: This is of clinical importance because MLSB-
S. aureus undergo spontaneous mutation to constitutive
lindamycin resistance at high rate and with potential to
evelop resistance during treatment. Routine testing of
taphylococcal isolates for inducible clindamycin resistance
s recommended in the 2006 CLSI guidelines and help to
hose treatment failures especially for patients infected
ith inducible MLSB isolates as in our hospital.
oi:10.1016/j.ijid.2010.02.393
4.014
ifferent antibiotic treatments in patients suffering from
RSA-mediastinitis after cardiac surgery
. Dohmen ∗, J. Schaefer, W. KonertzCharite Hospital, Medical University Berlin, Berlin, Ger-
any
Background: Methicillin-resistant Staphylococcus aureus
MRSA) poststernotomy mediastinitis is a rare but serious
i
d
mternational Congress on Infectious Diseases (ICID) Abstracts
omplication, which has a great impact on patient’s mor-
idity and mortality. This retrospective study evaluated
ifferent antibiotic therapies, after similar aggressive sur-
ical treatment was performed.
Methods: Between January 2005 and August 2008, 37
atients suffered postoperative from MRSA-mediastinitis.
he mean age was 70.6± 6.5 years, median logistic
uroSCORE was 27.0% (range 5.3 to 62.9%). In all patient’s
amples Vancomycin MIC was <1.0g/mL. There were 3
roups initiated, Vancomycin 2 g/d (group 1;n = 15), Dap-
omycin 6mg/kg (group 2; n = 11) and Linezolid 1200mg/d
group 3;n = 11). The pre-operative risk scores for surgical
ite infection weremeasured in all patients. End-points were
orbidity and mortality.
Results: The total mortality was 13.5% (5/37 pts). Results
re shown in table1. There was a signiﬁcant lower rate of
cute renal failure by using Daptomycin compared to Van-
omycin (*p = 0.016). Antibiotic therapy was changed in ﬁve
atients of group 1 due to therapy failuire. In group 2,
ntibiotic therapy was deescalated in one patient and one
atient was switched in oral therapy. In group 3, therapy was
hanged due to thrombocytopenia in two patients and in one
atient due to therapy failure. There was a trend of lower
ortality in group 2 compared to group 1 and 3, however
his was not statistical signiﬁcant.
Group 1
(n = 15)
Group 2
(n = 11)
Group 3
n = 11)
cute renal failure 46.7% 0%* 27.3%
ialysis 20.0% 0% 27.3%
herapy change 33.3% 18.2% 27.3%
ortality 26.7% 0% 9.1%
Conclusion: Daptomycin decrease signiﬁcantly acute
enal failure compared to Vancomycin therapy in patients
uffering from MRSA-mediastinitis. Furthermore there is
positive trend seen by using Daptomycin in MRSA-
ediastinitis, however future studies with larger patient’s
umbers are needed to conﬁrm this.
oi:10.1016/j.ijid.2010.02.394
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rends in Methicillin resistant staphylococcus aureus
MRSA) minimal inhibitory concentration (MIC) to Van-
omycin over a 2 year period in a community based
ospital
. Murillo1,∗, C. Garcia2, F. Ordieres3
Miami, USA
South Miami hospital, Miami, Fl, USA
South Miami hospital, 33143, Fl, USA
Background: Clinical and laboratory standards institute
CLSI) susceptible range for MRSA isolates to Vancomycin is
stablished at MIC of 2mcg/ml or less, however MRSA iso-
ates with higher MIC within the susceptible range are being
eported more frequently. It has been reported that the
linical response to therapy with vancomycin for patients
nfected with MRSA isolates with MIC’s ≥ 1.5 to 2mcg/ml is
ecreased.
The objectives of the present study were to deter-
ine the MIC to Vancomycin of MRSA blood isolates over
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a 2 year period in a Community based hospital in Miami,
Florida.
Methods: All blood cultures that were found to have MRSA
isolates, from patients treated at our institution during the
years 2008 and 2009 were evaluated. Minimum inhibitory
concentrations (MIC’s) were initially obtained by the Vitek
system, however by the last quarter of 2008 and all of 2009
the MIC’s were conﬁrmed by Etest strips and results were
then reported.
Results: 64.7% of the strains tested in 2008 had an MIC
between 1.5 and 2.0mcg/ml, whereas 87.9% of the strains
had MIC’s within the same range in 2009.
MRSA vancomycin MIC 2008-09
Conclusion: There seems to be a trend to higher MIC’s
of MRSA blood isolates to vancomycin, although still within
susceptible range. The ﬁndings suggest that monitoring of
MRSA susceptibility to vancomycin should continued in our
institution.
doi:10.1016/j.ijid.2010.02.395
74.016
Antimicrobial susceptibilities, and SCCmec and multi-
locus VNTR analyses of polymorphism and genetic
relationships of clinical isolates of MRSA
P. Brown ∗, S.-L. Peart, J.-A. Dookie
University of the West Indies, Kingston, Jamaica
Background: MRSA is a major cause of both hospital- and
community-acquired infections. In addition to their antibi-
otic resistance, MRSA can affect various anatomical sites,
resulting in signiﬁcant morbidity, long hospital stays and
high treatment costs. The aim of this study was to deter-
mine the antimicrobial susceptibilities and the presence
of inducible macrolidelincosamide-streptogramin B (MLSB)
resistance, and the genetic relationships based on SCCmec
and multi-locus VNTR analyses (MLVA).
Methods: Sixty-one MRSA isolates obtained from hospital
and community-based patients with staphylococcal infec-
tions were assessed for antimicrobial susceptibilities and
the presence of inducible MLSB resistance using the disk
diffusion technique. SCCmec types were determined by PCR-
restriction endonuclease analysis of the ccrB locus while
MLVA relationships were assessed by multiplex PCR ampli-
ﬁcation of the spa, sspA, clfAB and sdrCDE genes.
Results: Resistance to linezolid, teicoplanin and
rifampicin (8%), quinopristin-dalfopristin (13%), ery-
thromycin (87%) and lincomycin (80%) highlighted the
antimicrobial susceptibility testing. Overall, 11 isolates
were resistant to seven or more antibiotics, and no isolate
was resistant to vancomycin. Of the 53 erythromycin-
c
t
gts e349
esistant MRSA isolates, 25 (47%) expressed constitutive
LSB resistance. Of the 40 isolates for which SCCmec types
ere available, 32 (80%) were type IV. MLVA typing of these
0 isolates produced 16 distinct proﬁles. While clusters
ere identiﬁed among SCCmec type IV isolates, all type I,
I and III isolates yielded distinct MVLA patterns.
Conclusion: Signiﬁcant levels of resistance were noted,
ven to antimicrobials not licensed for use in Jamaica, and
any of the isolates exhibited cMLS resistance. While there
s diversity among CA-MRSA, it is likely that many infec-
ions are caused by genetically similar MRSA organisms. It is
mperative that surveillance initiatives be improved to mon-
tor and limit the spread of this organism in the hospital and
ommunity environments.
oi:10.1016/j.ijid.2010.02.396
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esistance to antibiotics of acinetbacter strains isolated
rom hospital associated infections
.M. Junie1, E. Papadomanolaki 2, G. Aleuraki 2, P.
aragianni2, A. Tsafaraki 2, A. Tsouri 2, D. Labousaki2,
. Volanis3, S. Kastanakis2,∗
University of Medicine and Pharmacy, 43200, Romania
St. George General Hospital Chania, Chania, Greece
Infection Control Committee ‘‘St. George’’ General Hos-
ital, Chania, Greece
Background: Acinetobacter infection is an emerging
roblem, as multiple resistant strains to antibiotics colonize
ntensive Care Units. The objective was to study the resis-
ance patterns of Acinetobacter strains isolated in ICU and
ther wards.
Methods: Acinetobacter strains were isolated from Inten-
ive Care Unit (ICU) and from others clinics (OC) in Chania,
reece, representing 3.06% of the total positive blood cul-
ures. Three blood samples were taken from each patient in
ottles of Bact-Alert system (Bio-Merieux). 68 strains were
solated from patients with urinary tract infections. Iden-
iﬁcation was carried out with API 20E and Vitek2 method.
ntibiotic sensitivity testing of strains was performed by disk
iffusion method (Kirby Bauer) as recommended by CLSI and
itek 2 system.
Results: Acinetobacter strains isolated in ICU showed a
igh percent of resistance (84.6-100%) to Pip, Caz, Imp,
az, Cip (76.9%), Akn (61.5%), lower percent of resistance
53.8) to Mer and Sam and only 30.7% were resistant to Gen.
7.5% of Acinetobacter strains isolated in OC were resistant
o Pip, Caz and Cip, 62.5% to Akn, Gen, Taz, Imp, 50% to
er and only 25% to Sam. Acinetobacter strains isolated in
C showed lower percent of resistance to Sam, Imp, Taz,
az, Pip and higher to Cip and Gen. No signiﬁcant differ-
nce exists in resistance among strains isolated in ICU and
C to Mer, Akn. 25%-50% of Acinetobacter strains isolated
rom urine were resistant to Am, Pip, Azt, Caz, Gen, Cip.
hey were resistant also to Nalidixic acid and Nitrofurantoin.
hey remain still susceptible to Imp, Mer, Ureidopeni-
illin+$ lactamase inhibitor, Ticarcillin/Clavulanic acid (CA),
o Cefpodoxime and some third (Ceftriaxone) and fourth
eneration cephalosporin’s (Cefepime).
